Highly Sensitive Multiplexed Detection of Brain‐Derived Tau and Phosphorylated Tau Proteoforms with the NULISA Technology
The NULISA BD-Tau assay and its integration into the 120-plex NULISAseq CNS Disease Panel provide powerful tools to develop blood-based biomarkers for AD and enable deeper insights into AD pathogenesis and progression.
Authors
- Shweta Iyengar
- Bingqing Zhang (ORCID: https://orcid.org/0000-0003-0739-0956)
- Yuling Luo
- Xiaomei Xu
- Roopa Comandor
- Xiaolei Qiu
- Wei Feng
- Xiao‐Jun Ma
- Li Wang
- Sean Kim
- Shalaka Deshmukh
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_101326
- Citations
- 1
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.16